Pfizer Inc
NYSE:PFE
Pfizer Inc
Depreciation & Amortization
Pfizer Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
-$4.9B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
-$9.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-183%
|
CAGR 10-Years
-70%
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zoetis Inc
NYSE:ZTS
|
Depreciation & Amortization
-$149m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-10%
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Pfizer Inc's Depreciation & Amortization?
Depreciation & Amortization
-4.9B
USD
Based on the financial report for Mar 31, 2024, Pfizer Inc's Depreciation & Amortization amounts to -4.9B USD.
What is Pfizer Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-1%
Over the last year, the Depreciation & Amortization growth was -27%. The average annual Depreciation & Amortization growth rates for Pfizer Inc have been -78% over the past three years , and -1% over the past ten years .